ORIX Private Equity Solutions

The platform leans heavily on ORIX Corporation's broader North American operations — including equipment leasing, asset-based lending, and corporate finance — to surface investment opportunities. Portfolio companies and prospective acquisition targets often enter the pipeline through existing commercial relationships with other ORIX business units. This captive origination network reduces reliance on intermediated auctions and creates visibility into companies that never formally run sale processes.

It is a corporate balance-sheet investor. The group deploys permanent capital directly from ORIX Corporation's treasury, not from third-party limited partners. There is no fund structure, no fee-based revenue model, and no pressure to exit investments on a fixed timeline. This removes the fundraising cycle and LP liquidity constraints that shape behavior at typical independent sponsors.

Prolign Capital is the external brand ORIX USA launched in February 2023 for its direct private equity activities. The rebrand created a standalone market-facing identity for the investment team while keeping full ownership and capital provisioning under ORIX Corporation. It functions as the go-to-market name for deal sourcing, seller conversations, and intermediary relationships.

The team targets control buyouts, growth equity rounds, and corporate carve-outs in North American middle-market companies. Investments take the form of majority positions or significant minority stakes. It does not operate as a venture investor or a fund-of-funds, and it does not manage external LP capital. The typical equity check ranges from $25 million to $100 million per transaction.

Core verticals include industrial technology, business services, and specialty finance, with additional activity in niche manufacturing and distribution businesses. The platform has completed transactions in propane distribution, architectural lighting manufacturing, and other engineered-products sectors. It does not currently have a disclosed dedicated technology or healthcare practice.